Sept 16 (Reuters) -
Kringle Pharma, Inc.
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Sep 30, 2026 Sep 30, 2026
LATEST PREVIOUS
FORECAST FORECAST
Sales 442 mln 332 mln
Operating loss 800 mln loss 1.02
Recurring loss 796 mln loss 1.02
Net loss 799 mln loss 1.02
EPS loss 103.52 yen loss 139.85 yen
NOTE - Kringle Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T